Dr. Vaishali Gupta, Dr. Vaishali Chaudhari
Vol. No. 21, Special Issue No 2 2026
Abstract:
The Blood-Brain Barrier (BBB) has been the major hurdle in the field of neuropsychiatric pharmacology, as the central nervous system (CNS) remains inaccessible to almost 98% of the small molecular weight therapeutic agents. This has led to an increase in systemic doses, causing metabolic toxicity, which in turn has resulted in suboptimal therapeutic outcomes in the management of stress, anxiety, and depression.
DOI: http://doi.org/10.37648/ijrmst.v21i02.033
Disclaimer: Indexing of published papers is subject to the evaluation and acceptance criteria of the respective indexing agencies. While we strive to maintain high academic and editorial standards, International Journal of Research in Medical Sciences and Technology does not guarantee the indexing of any published paper. Acceptance and inclusion in indexing databases are determined by the quality, originality, and relevance of the paper, and are at the sole discretion of the indexing bodies.